Dr. Daojing Wang is Founder and CEO of Newomics Inc. Before founding Newomics, he was a Principal Investigator at Lawrence Berkeley National Laboratory from 2002 to 2013. A co-inventor on multiple patents, including M3 emitters, MEA chips, and senescence chips, he has led the development of Newomics’ platforms and solutions for precision medicine. Dr. Wang earned his B.S. from the University of Science and Technology of China, his Ph.D. in chemistry from Princeton University, and completed postdoctoral training at the University of California, Berkeley.